• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Apotex`s Generic Losartan Potassium Receives Approval in US

    FDA

    Enforcement Report - Week of May 22, 2024

    FDA

    Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)

    BUSINESSWIRE

    Granules India Received ANDA Approval for Losartan and HCL Tablets

    PRESS RELEASE

    MSN`s Generic Losartan Potassium Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of July 12, 2023

    FDA

    Granules India Limited Received ANDA Approval for Losartan Potassium Tablets

    PRESS RELEASE

    Granules gets FDA nod to market generic medication to treat high blood pressure

    ECONOMIC TIMES

    IOL Chemicals secures patent for invention related to preparation of Sartan drugs

    BUSINESS-STANDARD

    Enforcement Report - Week of July 6, 2022

    FDA

    Strides Pharma recalls over 6L bottles of blood pressure treatment tablets in US

    ECONOMIC TIMES

    Enforcement Report - Week of June 8, 2022

    FDA

    Enforcement Report - Week Of June 01, 2022

    FDA

    Enforcement Report - Week of May 11, 2022

    PRESS RELEASE

    Enforcement Report - Week of May 4, 2022

    FDA

    IPC flags safety alert against blood pressure drug, Losartan

    PHARMABIZ

    Common blood pressure drug does not slow down the progression of more

    SCIENCEDAILY

    Health Canada Issues Recall of Auro Pharma`s Losartan 25/50/100mg tablets

    HEALTH CANADA

    Recall of Losacor Tablets and Losacor HCT Tablets

    GOV.HK

    Multiple lots of irbesartan, losartan and valsartan drugs recalled

    NEWSWIRE

    Health Canada Issues Recall of Sandoz Canada`s Losartan

    HEALTH CANADA

    Batch recall – Losartan-Mepha, Lactab / Losartan-HCT-Mepha, Lactab

    SWISSMEDIC

    Health Canada Issues Recall of Sanis` Losartan

    HEALTH CANADA

    Health Canada Issues Recall of Teva`s Losartan

    HEALTH CANADA

    Losartan is not effective in reducing hospitalization in mild COVID-19

    SCIENCEDAILY

    MHRA Class 2 Medicines Recall: Irbesartan & Losartan containing products : PSNC

    FIRSTWORDPHARMA

    UK MHRA recalls contaminated Irbesartan and Losartan batches

    PHARMABIZ

    Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs

    HEALTH CANADA

    Health Canada Issues Recall of Auro Pharma`s Losartan

    HEALTH CANADA

    Health Canada Issues Recall of Sivem Pharmaceuticals` Losartan

    HEALTH CANADA

    Health Canada Issues Recall of Teva Canada`s Losartan

    HEALTH CANADA

    Enforcement Report - Week of October 14, 2020

    FDA

    Enforcement Report for Week of October 7, 2020

    FDA

    Enforcement Report - Week of September 2, 2020

    FDA

    Enforcement Report - Week of April 22, 2020

    FDA

    6 Major Drug Recalls from the Past

    BIOSPACE

    FDA tags Torrent as key offender in production of tainted blood pressure meds

    FIERCE PHARMA

    Torrent Pharma recalls 74k bottles of hypertension drug from US

    ECONOMIC TIMES

    Enforcement Report - Week of October 9, 2019

    FDA

    FDA expands recall of blood pressure meds due to cancer-causing impurity

    BGR

    Torrent Pharmaceuticals Expands Voluntary Nationwide Recall of Losartan Potassium Tablets

    FDA

    FDA finds impurity in popular heartburn medicine Zantac that could cause cancer

    CNBC

    Aurobindo recalls mislabeled statin tablets from the U.S. market

    FIERCE PHARMA

    Enforcement Report - Week of July 17, 2019

    FDA

    Manufacturing Concerns Lead FDA to Pull 31 Apotex ANDAs

    RAPS

    Aurobindo gets warning letter over valsartan recall mess

    FIERCE PHARMA

    Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consumer Level Recall of Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg due to detection of NMBA Impurity.

    FDA

    Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply

    FIERCE PHARMA

    Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of GSMS Inc. (Losartan Potassium) Due to due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)

    FDA

    Enforcement Report - Week of May 29, 2019

    FDA

    FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India

    RAPS

    Enforcement Report - Week of May 8, 2019

    FDA

    Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP

    FDA

    Over 100 lots of losartan tablets recalled after NMBA detected

    IN-PHARMATECHNOLOGIST

    Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP

    FDA

    FDA expands blood pressure drug recall for fifth time this year

    NBCNEWS

    EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities

    RAPS

    Legacy Pharmaceutical Packaging, Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg

    FDA

    Updated: Torrent Pharmaceuticals Expands Voluntary Nationwide Recall of Losartan Potassium Tablets

    FDA

    Enforcement Report - Week of April 17, 2019

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.